Disclosures for "When Two is More Than Too Much: Carotid Stenosis and Giant Cell Arteritis")
-
An immediate family member of Dr. Santos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics. An immediate family member of Dr. Santos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. Dr. Santos has stock in Gilead Sciences. Dr. Santos has stock in Novocure. Dr. Santos has stock in Shockwave Medical. Dr. Santos has stock in Teva. An immediate family member of Dr. Santos has received research support from American Academy of Neurology. The institution of an immediate family member of Dr. Santos has received research support from Trinity Health Saint Mary's Foundation. An immediate family member of Dr. Santos has a non-compensated relationship as a Delegate with AAN Neurology on the Hill that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Palatucci Advocacy Leadership Forum that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Scholar with AAN Health Equity Symposium Scholarship that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Emerging Leaders Program that is relevant to AAN interests or activities.